CpG oligodeoxynucleotides augment the immune responses of piglets to swine Pasteurella multocida living vaccine in vivo

Research in Veterinary Science

Volumn 83, Issue 2, 2007, Pages 171-181

  Zhang, Linghua ^a   Tian, Xingshan ^b   Zhou, Fengzhen ^b  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^b INSTITUTE OF ANIMAL SCIENCE   (China)

Author keywords

CpG ODN; Immune response; Swine Pasteurella multocida living vaccine; The piglets

Indexed keywords

BACTERIAL VACCINE; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; LIVE VACCINE; PASTEURELLA MULTOCIDA VACCINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG DOSE COMPARISON; DRUG EFFICACY; HELPER CELL; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PIGLET; PROTEIN BLOOD LEVEL;

ANIMALS; BACTERIAL VACCINES; CELL PROLIFERATION; CPG ISLANDS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOGLOBULIN G; LEUKOCYTES, MONONUCLEAR; PASTEURELLA MULTOCIDA; SWINE; SWINE DISEASES; TIME FACTORS;

ANIMALIA; PASTEURELLA MULTOCIDA; SUIDAE; SUS;

EID: 34347208717     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2006.11.012     Document Type: Article

References (49)

1. Alcon V.L., Foldvari M., Snider M., Willson P., Gomis S., and Hecker R. Induction of protective immunity in pigs after immunization with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (BiphasixTM). Vaccine 21 (2003) 1811-1814
2. Ballas Z.K., Rasmussen W.L., and Krieg A.M. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J. Immunol. 157 (1996) 1840-1845
3. Boyd J.H., Mathur S., Wang Y., Batemana R.M., and Walley K.R. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response. Cardiovasc. Res. 72 3 (2006) 384-393
4. Brazolot Millan C.L., Weeratna R., Krieg A.M., Siegrist C.A., and Davis H.L. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 95 (1998) 15553-15558
5. Carpentier A.F., Chen L., Maltonti F., and Delattre J.Y. Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice. Cancer Res. 59 (1999) 5429-5432
6. Chu R.S., Targoni O.S., Krieg A.M., Lehmann P.V., and Harding C.V. CpG oligodeoxynucleotides act as adjuvants that switch on T Helper 1 (Th1) immunity. J. Exp. Med. 186 10 (1997) 1623-1631
7. Coutelier J.P., van der Logt T.M., Heessen W.A., Vink A., and Van Snick J. Virally induced modulation of murine IgG antibody subclasses. J. Exp. Med. 168 (1988) 2373-2378
8. Coutelier J.P., van der Logt T.M., and Heessen W.A. IgG subclass distribution of primary and secondary immune responses concomitant with viral infection. J. Immunol. 147 (1991) 1383-1386
9. Crawley A., Raymond C., and Wilkie B.N. Control of immunoglobulin isotype production by porcine B-cells cultured with cytokines. Vet. Immunol. Immunopathol. 91 (2003) 141-154
10. Daniel D., Véronique B., Anne-Marie T., Stéphanie B., Roland C., and André J. CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs. Vaccine 23 (2005) 4532-4540
11. Davis H.L., Suparto II., Weeratna R.R., Iskandriati D.D., Chamzah S.S., Ma'ruf A.A., Nente C.C., Pawitri D.D., Krieg A.M., Heriyanto S.W., and Sajuthi D.D. CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans. Vaccine 18 18 (2000) 1920-1924
12. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modification to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986) 271-277
13. Domeika K., Magnusson M., Eloranta M., Fuxler L., Alm G.V., and Fossum C. Characteristics of oligodeoxy-ribonucleotides that induce interferon (IFN)-alpha in the pig and the phenotype of the IFN-alpha producing cells. Vet. Immunol. Immunopathol. 101 1-2 (2004) 87-102
14. Hasslung F.C., Berg M., Allan G.M., Meehan B.M., McNeilly F., and Fossum C. Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on INFalpha production by porcine PBMCs. Gen. Virol. 84 (2003) 2937-2945
15. Heeg L., and Zimmermann S. CpG DNA as a Th1 trigger. Int. Arch. Allergy Immunol. 121 (2000) 87-97
16. Ioannou X.P., Gomis S.M., Karvonen B., Hecker R., Babiuk L.A., and van Drunen Little-van den Hurk S. CpG-containing oligodeoxynucleotides, in combination with conventional adjuvants, enhance the magnitude and change the bias of the immune responses to a herpesvirus glycoprotein. Vaccine 21 (2002) 127-137
17. Jakob T., Walker P.S., Krieg A.M., Udey M.C., and Vogel J.C. Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161 (1998) 3042-3049
18. Kamstrup S., Daniela V., and Dennis M.K. Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides. Vet. Microbiol. 78 4 (2001) 353-362
19. Kanellos T.S., Sylvester I.D., Butler V.L., Ambali A.G., Partidos C.D., Hamblin A.S., and Russel P.H. Mammalian granulocyte-macrophage colony stimulating factor and some CpG motifs have an effect on the immunogenicity of DNA and subunit vaccines in fish. Immunology 96 (1999) 507
20. Kauffman S.H.E., and Andersen P. Immunity to mycobacteria with emhasis on tuberculosis: implications for rational design of an effective tuberculosis vaccine. Chem. Immunol. 70 (1998) 21-59
21. Kawano Y., Noma T., and Yata J. Regulation of human IgG subclass production by cytokines. J. Immunol. 153 (1994) 4948-4958
22. Klinman D.M., Barnhart K.M., and Conover J. CpG motifs as immune adjuvants. Vaccine 17 (1999) 19-25
23. Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20 (2002) 709-760
24. Krieg A.M., Yi A.K., Matson S., Waldschmidt T.J., Bishop G.A., Teasdale R., Koretzky G.A., and Klinman D.M. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995) 546-549
25. Lewis P.J., van Drunen Little-van den Hurk S., and Babiuk L.A. Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response. J. Virol. 73 (1999) 10214-10223
26. Liang H., Nishioka Y., Reich C.F., Pisetsky D.S., and Lipsky P.E. Activation of human B cells by phosphorothioate oligodeoxynucleotides. J. Clin. Invest. 98 (1996) 1119-1129
27. Martin-Armas M., Simon-Santamaria J., Pettersen I., Moens U., Smedsrød B., and Sveinbjørnsson B. Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. J. Hepatol. 44 5 (2006) 939-946
28. Masuda K., Sakaguchi M., Saito S., Deboer D.J., Fujiwara S., Kurata K., Yamashita K., Hasegawa A., Ohno K., and Tsujimoto H. In vivo and in vitro tests showing sensitization to Japanese cedar (Cryptomeria japonica) pollen allergen in atopic dogs. J. Vet. Med. Sci. 62 (2000) 995-1000
29. Messina J.P., Gilkeson G.S., and Pisetsky D.S. Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J. Immunol. 147 (1991) 1759-1764
30. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
31. Pisetsky D.S. Immune activation by bacterial DNA: a new genetic code. Immunity 5 (1996) 303-310
32. Rankin R., Pontarollo R., Gomis S.M., Karvone B., Willson P., and Loehr B.I. CpG containing oligodeoxynucleotides augment and switch immune responses of cattle to bovine herpesvirus-1. Vaccine 20 (2002) 3014-3022
33. Roman M., Martin-Orozco E., Goodman J.S., Nguyen M.D., Sato Y., Ronaghy A., Kornbluth R.S., Richman D.D., Carson D.A., and Raz E. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nature 3 8 (1997) 849-854
34. Shimosato T., Kitazawa H., Katoh S., Tomioka Y., Karima R., Ueha S., Kawai Y., Hishinuma T., Matsushima K., and Saito T. Swine Toll-like receptor 9 recognizes CpG motifs of human cell stimulant. Biochem. Biophys. Acta 1627 (2003) 56-61
35. Snapper C.M., and Finkelman F.D. Immunoglobulin class switching. In: Paul W.E. (Ed). Fundamental Immunology (1998), Lipponcott-Raven, New York 31-861
36. Snapper C.M., and Paul W.E. Interferon-γ and B cell stimulatory factor-1 recipricolly regulate Ig isotype production. Science 236 (1987) 944-947
37. Sparwasser T., Koch E.V., Vabulas R.M., Heeg K., Lipford G.B., Ellwart J.W., and Wagner H. Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28 (1998) 2045-2054
38. Sun S., Zhang X., Tough D.F., and Sprent J. Type 1 interferon-mediated stimulation of T cells by CpG DNA. J. Exp. Med. 188 12 (1998) 2335-2342
39. Takeshita S., Takeshita F., Haddad D.E., Ishii K.J., and Klinman D.M. CpG oligodeoxynucleotides induce murine macrophages to up-regulate chemokine mRNA expression. Cell Immunol. 206 (2000) 101-106
40. Threadgill D.S., McCormick L.L., McCool T.L., Greenspan N.S., and Schreiber J.R. Mitogenic synthetic polynucleotides suppress the antibody response to a bacterial polysaccharide. Vaccine 16 (1998) 76-82
41. Van der Stede Y., Verdonck F., Vancaeneghem S., Cox E., and Goddeeris B.M. CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations. Vet. Immunol. Immunopathol. 86 (2002) 31-41
42. 3 or CpG-oligodeoxynucleotides. Vaccine 21 (2003) 1023-1032
43. Van der Stede Y., Verdonck F., Verfaillie T., Goddeeris B.M., and Cox E. Porcine-specific CpG-oligodeoxynucleotide activates B-cells and increases the expression of MHC-II molecules on lymphocytes. Vet. Immunol. Immunopathol. 105 (2005) 115-124
44. Verthelyi D., Ishii K.J., Gursel M., Takeshita F., and Klinman D.M. Human peripheral blood cells differentially recognize and respond to two distinct CpG-motifs. J. Immunol. 166 (2001) 2372-2377
45. Wai M.L., Marcel B.B., and Marie-Paule S.-R. Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes. Vaccine 20 (2002) 148-157
46. Yang H., and Parkhouse R.M. Phenotypic classification of porcine lymphocyte subpopulations in blood and lymphoid tissues. Immunology 89 1 (1996) 76-83
47. Zhang L.H., Tian X.S., Guo Y., and Zhou F.Z. The effect of transgenic expression of porcine interleukin-6 gene and CpG sequences on immune responses of the newborn piglets inoculated with pseudorabies attenuated vaccine. Res. Vet. Sci. 80 (2006) 281-286
48. Zhang L.H., Guo Y., Tian X.S., and Zhou F.Z. Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo. Dev. Comp. Immunol. 30 6 (2006) 589-596
49. Zhang L.H., Tian X.S., Guo Y., and Zhou F.Z. Effects of CpG ODN on CD4+ and CD8+ T subpopulations in the immune response to porcine reproductive and respiratory syndrome killed virus vaccine. Vaccine 24 11 (2006) 1874-1879